It is hypothesized that the cytotoxic effect of methylglyoxal in cancer cells will be promoted by a synergistic effect of the up-regulation of SLC2A1 gene and the down-regulation of genes encoding enzymes that are involved in the degradation of methylglyoxal. The gene discussed is SLC2A1; the disease is cancer.